यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 20mg tablets
phoenix healthcare distribution ltd - isosorbide dinitrate - oral tablet - 20mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 10mg tablets
waymade healthcare plc - isosorbide dinitrate - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 20mg tablets
waymade healthcare plc - isosorbide dinitrate - oral tablet - 20mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 10mg tablets
sigma pharmaceuticals plc - isosorbide dinitrate - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 20mg tablets
sigma pharmaceuticals plc - isosorbide dinitrate - oral tablet - 20mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 10mg tablets
de pharmaceuticals - isosorbide dinitrate - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 20mg tablets
de pharmaceuticals - isosorbide dinitrate - oral tablet - 20mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 10mg tablets
mawdsley-brooks & company ltd - isosorbide dinitrate - oral tablet - 10mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
isosorbide dinitrate 20mg tablets
mawdsley-brooks & company ltd - isosorbide dinitrate - oral tablet - 20mg
संयुक्त राज्य -
अंग्रेज़ी -
NLM (National Library of Medicine)
isosorbide mononitrate tablet
ncs healthcare of ky, llc dba vangard labs - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate 30 mg - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral ismn is not sufficiently rapid for this product to be useful in aborting an acute angina episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.